Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast

Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast.

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03002766

Acronym

DCIS

Enrollment

224

Registered

2016-12-26

Start date

2000-03-31

Completion date

2006-04-30

Last updated

2016-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma Breast

Brief summary

By this non-randomized prospective study, it's evaluated the outcome of patients underwent BCS for DCIS at whom an established score system to address adjuvant therapies have been prospectively applied, according to the wideness of free margins. Between March 2000 and April 2006, 224 patients were enrolled and followed within the study.

Interventions

PROCEDUREBreast conservative surgery

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age \>18 years; * female candidate to breast conservative surgery

Exclusion criteria

* female with previous omolateral or controlateral breast cancer; * female with previous radiotherapy (RT).

Design outcomes

Primary

Measure	Time frame
Ipsilateral Breast Tumor Recurrence (IBTR)	six years

Secondary

Measure	Time frame	Description
Contralateral breast cancer (CBC)	six years	the side effects of radiotherapy may outweigh the reduction in the risk of IBTR

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026